Refine
Year of publication
Document Type
- Article (408)
- Preprint (214)
- Contribution to a Periodical (8)
- Conference Proceeding (6)
- Working Paper (6)
- Book (1)
- Report (1)
Has Fulltext
- yes (644)
Is part of the Bibliography
- no (644)
Keywords
- e +-e − Experiments (12)
- BESIII (11)
- Branching fraction (8)
- Particle and Resonance Production (6)
- Charm Physics (5)
- Spectroscopy (5)
- Heavy-ion collisions (4)
- Lepton colliders (4)
- Quarkonium (4)
- portal hypertension (4)
- stochastic differential utility (4)
- COVID-19 (3)
- Charmed mesons (3)
- Diffraction (3)
- Elastic scattering (3)
- Electroweak interaction (3)
- Exotics (3)
- Hadronic decays (3)
- Polarization (3)
- e+-e− Experiments (3)
- Beam Energy Scan (2)
- Biomarkers (2)
- Branching fractions (2)
- Brassica napus (2)
- COVID-19 surveillance (2)
- Cancer (2)
- Charm physics (2)
- Charmonium (2)
- Chiral Magnetic Effect (2)
- Collectivity (2)
- Correlation (2)
- Electroweak Interaction (2)
- Epidemiology (2)
- FBSDE (2)
- Flavour Physics (2)
- Immunology (2)
- Leptonic, semileptonic & radiative decays (2)
- Mechanisms of disease (2)
- Mitochondria (2)
- Non-small cell lung cancer (2)
- Omicron (2)
- Particle decays (2)
- RHIC (2)
- Radiative decay (2)
- Radiotherapy (2)
- Rare diseases (2)
- Registries (2)
- SARS-CoV-2 (2)
- SARS-CoV-2 monitoring (2)
- STAR (2)
- Shear viscosity (2)
- Treatment (2)
- asset pricing (2)
- cirrhosis (2)
- consumption-portfolio choice (2)
- incomplete markets (2)
- microdosing (2)
- recursive utility (2)
- 140Ce (1)
- 3years (1)
- ACLF (1)
- ADGRE1 (1)
- AIS (1)
- ALK (1)
- ALK-rearranged NSCLC (1)
- ARDS (1)
- ATM (1)
- Acuris (1)
- Acute elbow dislocation (1)
- Advanced biliary tract cancer (1)
- Alpha-synuclein (1)
- Alternative oxidase (1)
- Antibiotic therapy (1)
- Antirheumatic agents (1)
- Araneae (1)
- Artificial Intelligence (1)
- Augenerkrankungen (1)
- Autosomal recessive cutis laxa type 1C (1)
- B-slope (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BESIII detector (1)
- BI1361849 (1)
- BTC (1)
- Bacterial leakage (1)
- Beam energy scan (1)
- Bhabha (1)
- Biodiversity Data (1)
- Biogeography (1)
- Biomedical engineering (1)
- Biomonitoring (1)
- Bipolar disorder (1)
- Born cross section (1)
- Born cross section measurement (1)
- Botanical Collections (1)
- Branching fraction measurement (1)
- CAD/CAM crown (1)
- CAKUT (1)
- CBA (1)
- CEP68 (1)
- COMP (1)
- COVID 19 (1)
- CP violation (1)
- CRVO (1)
- CV9202 (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cement gap (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charm vector (1)
- Charmonia (1)
- Charmonium (-like) (1)
- Chest pain unit (1)
- Child (1)
- Chiral magnetic effect (1)
- Circadian (1)
- Cirrhosis (1)
- Classification (1)
- Clinical trial (1)
- Coalescence (1)
- Cognitive impairment (1)
- Cohort studies (1)
- Cold nuclear matter effects (1)
- Colorectal cancer (1)
- Comparative effectiveness research (1)
- Complex II (1)
- Concept paper (1)
- Conometric connection (1)
- Consensus (1)
- Consensus document (1)
- Conservation (1)
- Consumption hump (1)
- Coronary intervention (1)
- Critical care (1)
- Critical point (1)
- Cross section (1)
- D meson (1)
- DME (1)
- DNA-PK (1)
- Dark photon (1)
- Dark sector (1)
- Data Standard (1)
- Data protection (1)
- Data sharing (1)
- Datenschutz (1)
- Dermatomyositis (1)
- Detection workflow (1)
- Deuteron production (1)
- Deutschland (1)
- Di-hadron correlations (1)
- Diagnosis (1)
- Digital (1)
- Digitization (1)
- ECM (1)
- EMR1 (1)
- Ecology (1)
- Ecophysiology (1)
- Ectoparasites (1)
- Education (1)
- Effective form factor (1)
- Einwanderer (1)
- Elastogenesis (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electromagnetic transitions (1)
- Elliptic flow (1)
- Equity (1)
- Etanercept (1)
- Exercise training (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- Extracellular matrix (1)
- Eye diseases (1)
- EyesiNet (1)
- F4/80 (1)
- FOS: Physical sciences (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flow (1)
- Form factors (1)
- Forward physics (1)
- Fracture type (1)
- Fremdbild (1)
- GLM (1)
- Genetics (1)
- Genetics research (1)
- Geschichte 1981-1997 (1)
- Gomphus flavipes (1)
- Groomed jet radius (1)
- HCC (1)
- Hadron-Hadron scattering (experiments) (1)
- Hadronization (1)
- Hand-foot syndrome (1)
- Hantavirus (1)
- Health information (1)
- Health-seeking behaviour (1)
- Heart failure (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy ion collisions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Helicity amplitude analysis (1)
- Helpline (1)
- Herbaria (1)
- Hif1α (1)
- High Energy Physics - Experiment (hep-ex) (1)
- Higher moments (1)
- Hyperons (1)
- Hypertension (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IHMCIF (1)
- IL-6 (1)
- ILUVIEN (1)
- IR (1)
- ISS (1)
- Immunogenetics (1)
- Immunomonitoring (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive branching fraction (1)
- Inflammation (1)
- Initial state radiation (1)
- Integrative Modeling (1)
- Interference fragmentation function (1)
- Invisible decays (1)
- J/ψ suppression (1)
- Jet substructure (1)
- K0S (1)
- K3EDTA plasma sampling (1)
- K48-linked (1)
- K63-linked (1)
- Konzeptpapier (1)
- Landscape ecology (1)
- Landschaftsökologie (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Lehre (1)
- Libellen (1)
- Lifestyle (1)
- Lipidomics (1)
- Liver diseases (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- L´evy framework (1)
- MACS (1)
- MCP-1 (1)
- MMPs (1)
- MRSA (1)
- MYCN amplification (1)
- Marginal integrity (1)
- Metabolomics (1)
- Microgap (1)
- Mitochondrial disease (1)
- Models & methods for nuclear reactions (1)
- Molecular diagnostic testing (1)
- Molecular medicine (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Myotis myotis (1)
- NAFLD (1)
- NET (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMR spectroscopy (1)
- NSCLC (1)
- NSTEMI (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Netzhaut (1)
- Neutrinos (1)
- Neutron physics (1)
- Nonflow (1)
- Nuclear reactions (1)
- Nutzen (1)
- Oncogenes (1)
- Open Access (1)
- Ophiogomphus cecilia (1)
- Orphan disease (1)
- Osteoporosis (1)
- Outcome (1)
- Oxidative phosphorylation (1)
- PBSC (1)
- PDB-Dev (1)
- PDBx/mmCIF (1)
- PDE‐5‐inhibitor (1)
- PDGFRβ (1)
- PI3K (1)
- PRRT (1)
- PTEN (1)
- Pacemaker (1)
- Parkinson disease (1)
- Parkinson’s disease (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Patient safety (1)
- Periodontal disease (1)
- Periodontal therapy (1)
- Pest-crop interactions (1)
- Phalangeal fractures (1)
- Physical activity (1)
- Plasminogen (1)
- Platelets (1)
- Pneumonia (1)
- Portal veins (1)
- Poverty (1)
- Pre-analytics (1)
- Preclinical research (1)
- Predictive markers (1)
- Prevention (1)
- Prognosis (1)
- Prognostic models (1)
- Prostaglandin (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatric disorders (1)
- Psychiatry (1)
- Puumala virus (1)
- QCD (1)
- Quantum chromodynamics (1)
- RAS pathway (1)
- RNA (1)
- RNA-binding proteins (1)
- Radiative capture (1)
- Rapps (1)
- Rare decays (1)
- Real world (1)
- Register (1)
- Remission (1)
- Research Infrastructure (1)
- Resonance reactions (1)
- Respiratory chain (1)
- Retina (1)
- Retro-IDEAL (1)
- Rh(II) catalysis (1)
- Rheumatoid arthritis (1)
- Rodent-associated infections (1)
- Roosting place (1)
- SARS CoV 2 (1)
- SD-OCT (1)
- SLC20A1 (1)
- SPSS (1)
- STED superresolution (1)
- Sampling protocol (1)
- Schulbuch (1)
- Schädling (1)
- Seasonal variation (1)
- Seltene Erkrankungen (1)
- Semantics (1)
- Semi-leptonic decays (1)
- Single-molecule biophysics (1)
- Social determinants (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Spatial scales (1)
- Spatio-temporal patterns (1)
- Spin alignment (1)
- Spine care (1)
- Spinturnix myoti (1)
- Splitting function (1)
- Standardization (1)
- Staphylococcus aureus (1)
- Stentoplasty (1)
- Steroid (1)
- Student (1)
- Suicide (1)
- Sunlight (1)
- Super-resolution microscopy (1)
- Surgical oncology (1)
- TACE (1)
- TGR(mREN2)27 (1)
- TP53 mutation status (1)
- Taxonomy (1)
- Techniques Electromagnetic calorimeters (1)
- Telemedicine (1)
- Thermal model (1)
- Thoracic trauma (1)
- Threshold effect (1)
- Thrombosis (1)
- Thromboxane (1)
- Transversity (1)
- UWB diagnostics (1)
- VEGF (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Variant of concern (1)
- Veins (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vitreous samples (1)
- Wastewater-based epidemiology (WBE) (1)
- Western diet (1)
- Worldwide Protein Data Bank (1)
- X-ray crystallography (1)
- Y states (1)
- accessory proteins (1)
- acute decompensation (1)
- acute myeloid leukemia (1)
- acute-on-chronic liver failure (1)
- adaptive cardiac remodelling (1)
- adverse events (1)
- alternative oxidase (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- autoantibodies (1)
- azaindole (1)
- backward stochastic differential equation (1)
- bioactivity testing (1)
- bladder exstrophy-epispadias complex (1)
- bleomycin (1)
- bundle (1)
- c-kit (1)
- capture (1)
- cardiac ischaemia‐reperfusion (1)
- cartilage (1)
- cell stress (1)
- cell-free protein synthesis (1)
- center-of-mass energy (1)
- centrosome (1)
- centrosome linker (1)
- cerium (1)
- certainty equivalents (1)
- charmonium-like states (1)
- cloacal malformation (1)
- complications (1)
- computed tomography (1)
- consumption hump (1)
- convergence (1)
- cross-section (1)
- cytarabine dose (1)
- diabetic macular edema (1)
- diazo compounds (1)
- dimuon (1)
- dynamic programming (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- easyPACId (1)
- ectosomes (1)
- education (1)
- elderly (1)
- electron transport chain (1)
- electron-positron collision (1)
- epigeic spiders (1)
- epigäische Spinnen (1)
- erectile dysfunction (1)
- exosomes (1)
- extracellular vesicles (1)
- fibrogenesis (1)
- fixed point approach (1)
- fluocinolone acetonide (1)
- fluorescent dye (1)
- functional genetics (1)
- generalist predators (1)
- generalistische Prädatoren (1)
- geriatric medicine (1)
- global change (1)
- guidelines (1)
- habit formation (1)
- habitat destruction (1)
- hadron spectroscopy (1)
- hadronic events (1)
- health information exchange (1)
- heavy-ion collisions (1)
- helicity amplitude analysis (1)
- hematotoxicity (1)
- hepatic encephalopathy (1)
- hepatic stellate cells (1)
- hepatocellular cancer (1)
- high-risk neuroblastoma (1)
- immunity (1)
- impatience (1)
- in vitro models (1)
- inclusive J/ψ decays (1)
- inflammation (1)
- intrinsically disordered region (1)
- jumps (1)
- kidney formation (1)
- land use (1)
- leisure (1)
- life-cycle utility maximization (1)
- liver (1)
- liver fibrosis (1)
- mRNA active cancer immunotherapy (1)
- macrophage (1)
- metallo β lactamases (1)
- microparticles (1)
- microvesicles (1)
- microwave ablation (1)
- microwave breast imaging (1)
- minimal information requirements (1)
- mouse (1)
- mouse model (1)
- multiresistant bacteria (1)
- n_TOF (1)
- natural products (1)
- nematophin (1)
- neuroendocrine tumor (1)
- neutralizing antibodies (1)
- neutron (1)
- nonstructural proteins (1)
- non‐selective beta‐blocker (1)
- normalization (1)
- nucleosynthesis (1)
- number of J/ψ events (1)
- optimal investment (1)
- osteoarthritis (1)
- oval split ring resonator (1)
- p+p collisions (1)
- p53 pathway (1)
- patient study (1)
- peptide receptor radionuclide therapy (1)
- peripheral blood stem cell collection (1)
- polyubiquitin (1)
- portosystemic shunt (1)
- prevention (1)
- primary biliary cholangitis (1)
- proteobacteria (1)
- qualitative research (1)
- quality control (1)
- rare diseases (1)
- reactive oxygen species (1)
- renin-angiotensin system (1)
- reproducibility (1)
- resectability (1)
- rigor (1)
- rootletin (1)
- s-process (1)
- second line therapy (1)
- sequential ALK-inhibitor therapy (1)
- simplified production (1)
- sorafenib (1)
- sphingolipid sphingosine-1-phosphate (1)
- sphingolipids (1)
- sphingosine-1-phosphate receptor 5 (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- steatosis (1)
- stochastic volatility (1)
- structural proteins (1)
- surgery (1)
- systemic sclerosis (1)
- tetraquark (1)
- theranostics (1)
- thiol inhibitors (1)
- thrombospondins (1)
- treatment (1)
- treatment response (1)
- trigger efficiency (1)
- ubiquitin-conjugating enzymes (1)
- urinary tract development (1)
- ursodeoxycholic acid (1)
- variant of concern (1)
- variants of concern (1)
- wage hump (1)
- wastewater-based epidemiology (WBE) (1)
- welfare loss (1)
- wwPDB (1)
- zebrafish development (1)
- Λ+c baryon (1)
- Σ hyperon (1)
- Υ suppression (1)
- ψ(3686) (1)
- fibrogenesis (1)
Institute
- Physik (374)
- Frankfurt Institute for Advanced Studies (FIAS) (106)
- Medizin (91)
- Geowissenschaften (23)
- Präsidium (8)
- Biochemie und Chemie (7)
- Biochemie, Chemie und Pharmazie (7)
- Biowissenschaften (7)
- Wirtschaftswissenschaften (7)
- Center for Financial Studies (CFS) (6)
The slow neutron capture process (s-process) is responsible for producing about half of the elemental abundances heavier than iron in the universe. Neutron capture cross sections on stable isotopes are a key nuclear physics input for s-process studies. The 72Ge(n, γ) cross section has an important influence on production of isotopes between Ge and Zr during s-process in massive stars and therefore experimental data are urgently required. 72Ge(n, γ) was measured at the neutron time-of-flight facility n_TOF (CERN) for the first time at stellar energies. The measurement was performed using an enriched 72GeO2 sample at a flight path of 185m with a set of liquid scintillation detectors (C6D6). The motivation, experiment and current status of the data analysis are reported.
Introduction: Evidence from a number of open-label, uncontrolled studies has suggested that rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-care. The objective of this study was to evaluate the safety and clinical outcomes of rituximab in several standard-of-care-refractory autoimmune diseases (within rheumatology, nephrology, dermatology and neurology) other than rheumatoid arthritis or non-Hodgkin's lymphoma in a real-life clinical setting.
Methods: Patients who received rituximab having shown an inadequate response to standard-of-care had their safety and clinical outcomes data retrospectively analysed as part of the German Registry of Autoimmune Diseases. The main outcome measures were safety and clinical response, as judged at the discretion of the investigators.
Results: A total of 370 patients (299 patient-years) with various autoimmune diseases (23.0% with systemic lupus erythematosus, 15.7% antineutrophil cytoplasmic antibody-associated granulomatous vasculitides, 15.1% multiple sclerosis and 10.0% pemphigus) from 42 centres received a mean dose of 2,440 mg of rituximab over a median (range) of 194 (180 to 1,407) days. The overall rate of serious infections was 5.3 per 100 patient-years during rituximab therapy. Opportunistic infections were infrequent across the whole study population, and mostly occurred in patients with systemic lupus erythematosus. There were 11 deaths (3.0% of patients) after rituximab treatment (mean 11.6 months after first infusion, range 0.8 to 31.3 months), with most of the deaths caused by infections. Overall (n = 293), 13.3% of patients showed no response, 45.1% showed a partial response and 41.6% showed a complete response. Responses were also reflected by reduced use of glucocorticoids and various immunosuppressives during rituximab therapy and follow-up compared with before rituximab. Rituximab generally had a positive effect on patient well-being (physician's visual analogue scale; mean improvement from baseline of 12.1 mm).
Conclusions: Data from this registry indicate that rituximab is a commonly employed, well-tolerated therapy with potential beneficial effects in standard of care-refractory autoimmune diseases, and support the results from other open-label, uncontrolled studies.
The centrosome linker proteins C-Nap1, rootletin, and CEP68 connect the two centrosomes of a cell during interphase into one microtubule-organizing center. This coupling is important for cell migration, cilia formation, and timing of mitotic spindle formation. Very little is known about the structure of the centrosome linker. Here, we used stimulated emission depletion (STED) microscopy to show that each C-Nap1 ring at the proximal end of the two centrioles organizes a rootletin ring and, in addition, multiple rootletin/CEP68 fibers. Rootletin/CEP68 fibers originating from the two centrosomes form a web-like, interdigitating network, explaining the flexible nature of the centrosome linker. The rootletin/CEP68 filaments are repetitive and highly ordered. Staggered rootletin molecules (N-to-N and C-to-C) within the filaments are 75 nm apart. Rootletin binds CEP68 via its C-terminal spectrin repeat-containing region in 75-nm intervals. The N-to-C distance of two rootletin molecules is ∼35 to 40 nm, leading to an estimated minimal rootletin length of ∼110 nm. CEP68 is important in forming rootletin filaments that branch off centrioles and to modulate the thickness of rootletin fibers. Thus, the centrosome linker consists of a vast network of repeating rootletin units with C-Nap1 as ring organizer and CEP68 as filament modulator.
Previous studies in developing Xenopus and zebrafish reported that the phosphate transporter slc20a1a is expressed in pronephric kidneys. The recent identification of SLC20A1 as a monoallelic candidate gene for cloacal exstrophy further suggests its involvement in the urinary tract and urorectal development. However, little is known of the functional role of SLC20A1 in urinary tract development. Here, we investigated this using morpholino oligonucleotide knockdown of the zebrafish ortholog slc20a1a. This caused kidney cysts and malformations of the cloaca. Moreover, in morphants we demonstrated dysfunctional voiding and hindgut opening defects mimicking imperforate anus in human cloacal exstrophy. Furthermore, we performed immunohistochemistry of an unaffected 6-week-old human embryo and detected SLC20A1 in the urinary tract and the abdominal midline, structures implicated in the pathogenesis of cloacal exstrophy. Additionally, we resequenced SLC20A1 in 690 individuals with bladder exstrophy-epispadias complex (BEEC) including 84 individuals with cloacal exstrophy. We identified two additional monoallelic de novo variants. One was identified in a case-parent trio with classic bladder exstrophy, and one additional novel de novo variant was detected in an affected mother who transmitted this variant to her affected son. To study the potential cellular impact of SLC20A1 variants, we expressed them in HEK293 cells. Here, phosphate transport was not compromised, suggesting that it is not a disease mechanism. However, there was a tendency for lower levels of cleaved caspase-3, perhaps implicating apoptosis pathways in the disease. Our results suggest SLC20A1 is involved in urinary tract and urorectal development and implicate SLC20A1 as a disease-gene for BEEC.
Recombinase-mediated cassette exchange (RMCE) exploits the possibility to unidirectionally exchange any genetic material flanked by heterotypic recombinase recognition sites (RRS) with target sites in the genome. Due to a limited number of available pre-fabricated target sites, RMCE in mouse embryonic stem (ES) cells has not been tapped to its full potential to date. Here, we introduce a universal system, which allows the targeted insertion of any given transcriptional unit into 85 742 previously annotated retroviral conditional gene trap insertions, representing 7013 independent genes in mouse ES cells, by RMCE. This system can be used to express any given cDNA under the control of endogenous trapped promoters in vivo, as well as for the generation of transposon ‘launch pads’ for chromosomal region-specific ‘Sleeping Beauty’ insertional mutagenesis. Moreover, transcription of the gene-of-interest is only activated upon Cre-recombinase activity, a feature that adds conditionality to this expression system, which is demonstrated in vivo. The use of the RMCE system presented in this work requires one single-cloning step followed by one overnight gateway clonase reaction and subsequent cassette exchange in ES cells with efficiencies of 40% in average.
Wastewater-based SARS-CoV-2 epidemiology (WBE) has been established as an important tool to support individual testing strategies. Omicron sub-variants BA.4/5 have spread globally displacing the predeceasing variants. Due to the severe transmissibility and immune escape potential of BA.4/5, early monitoring was required to asses and implement countermeasures in time.
In this study, we monitored the prevalence of SARS-CoV-2 BA.4/5 at six municipal wastewater treatment plants (WWTPs) in the Federal State of North-Rhine-Westphalia (NRW, Germany) in May and June 2022. Initially, L452R-specific primers/probes originally designed for SARS-CoV-2 Delta detection were validated using inactivated authentic viruses and evaluated for their suitability to detect BA.4/5. Subsequently, the assay was used for RT-qPCR analysis of RNA purified from wastewater obtained twice a week at six WWTPs. The occurrence of L452R carrying RNA was detected in early May 2022 and the presence of BA.4/5 was confirmed by variant-specific single nucleotide polymorphism PCR (SNP-PCR) targeting E484A/F486V. Finally, the mutant fractions were quantitatively monitored by digital PCR confirming BA.4/5 as the majority variant by 5th June 2022.
In conclusions, the successive workflow using RT-qPCR, variant-specific SNP-PCR, and RT-dPCR demonstrates the strength of WBE as a versatile tool to rapidly monitor variant spreading independent of individual test capacities.
The emerging disciplines of lipidomics and metabolomics show great potential for the discovery of diagnostic biomarkers, but appropriate pre-analytical sample-handling procedures are critical because several analytes are prone to ex vivo distortions during sample collection. To test how the intermediate storage temperature and storage period of plasma samples from K3EDTA whole-blood collection tubes affect analyte concentrations, we assessed samples from non-fasting healthy volunteers (n = 9) for a broad spectrum of metabolites, including lipids and lipid mediators, using a well-established LC-MS-based platform. We used a fold change-based approach as a relative measure of analyte stability to evaluate 489 analytes, employing a combination of targeted LC-MS/MS and LC-HRMS screening. The concentrations of many analytes were found to be reliable, often justifying less strict sample handling; however, certain analytes were unstable, supporting the need for meticulous processing. We make four data-driven recommendations for sample-handling protocols with varying degrees of stringency, based on the maximum number of analytes and the feasibility of routine clinical implementation. These protocols also enable the simple evaluation of biomarker candidates based on their analyte-specific vulnerability to ex vivo distortions. In summary, pre-analytical sample handling has a major effect on the suitability of certain metabolites as biomarkers, including several lipids and lipid mediators. Our sample-handling recommendations will increase the reliability and quality of samples when such metabolites are necessary for routine clinical diagnosis.
Background: The treatment of high-risk neuroblastoma patients consists of multimodal induction therapy to achieve remission followed by consolidation therapy to prevent relapses. However, the type of consolidation therapy is still discussed controversial. We applied metronomic chemotherapy in the prospective NB90 trial and monoclonal anti-GD2-antibody (MAB) ch14.18 in the NB97 trial. Here, we present the long term outcome data of the patient cohort. Methods: A total of 334 stage 4 neuroblastoma patients one year or older were included. All patients successfully completed the induction therapy. In the NB90 trial, 99 patients received at least one cycle of the oral maintenance chemotherapy (NB90 MT, 12 alternating cycles of oral melphalan/etoposide and vincristine/cyclophosphamide). In the NB97 trial, 166 patients commenced the MAB ch14.18 consolidation therapy (six cycles over 12 months). Patients who received no maintenance therapy according to the NB90 protocol or by refusal in NB97 (n = 69) served as controls. Results: The median observation time was 11.11 years. The nine-year event-free survival rates were 41 ± 4%, 31 ± 5%, and 32 ± 6% for MAB ch14.18, NB90 MT, and no consolidation, respectively (p = 0.098). In contrast to earlier reports, MAB ch14.18 treatment improved the long-term outcome compared to no additional therapy (p = 0.038). The overall survival was better in the MAB ch14.18-treated group (9-y-OS 46 ± 4%) compared to NB90 MT (34 ± 5%, p = 0.026) and to no consolidation (35 ± 6%, p = 0.019). Multivariable Cox regression analysis revealed ch14.18 consolidation to improve outcome compared to no consolidation, however, no difference between NB90 MT and MAB ch14.18-treated patients was found. Conclusions: Follow-up analysis of the patient cohort indicated that immunotherapy with MAB ch14.18 may prevent late relapses. Finally, metronomic oral maintenance chemotherapy also appeared effective.
Hintergrund: Die Ophthalmoskopie ist Bestandteil des medizinischen Curriculums, jedoch das Vermitteln der Inhalte oft unbefriedigend, da ein systematisches Lernen von Pathologien und deren Behandlungen dadurch erschwert ist, dass oftmals das passende Patientengut nicht zur Verfügung steht und dadurch gesunde Studenten einander untersuchen müssen. Aus diesem Grund haben wir eine Online-Plattform entwickelt, die in Kombination mit simulationsgestütztem Training sowohl das eigenständige als auch das angeleitete Lernen von Untersuchungsmethoden und Pathologien ermöglicht.
Ziel der Arbeit: Ziel der vorliegenden Arbeit war, ein Format für die Verbesserung der Lehre der direkten und indirekten Ophthalmoskopie im Studierendenunterricht zu evaluieren. Dabei wurden praktische Übungen an Virtual-Reality-basierten Simulatoren mit neu entwickelten und an den Lehrkatalog angepassten theoretischen Inhalten in der Online-Plattform EyesiNet verschränkt.
Material und Methoden: Die Studierenden bearbeiteten am ersten sowie am letzten Praktikumstag zufällig ausgewählte Fälle, die ihnen von den Eyesi Direct- und Eyesi Indirect-Simulatoren präsentiert wurden. Zwischen diesen beiden Einheiten konnten sie sich auf freiwilliger Basis mit den theoretischen Grundlagen typischer ophthalmologischer Krankheitsbilder im EyesiNet beschäftigen.
Ergebnisse: Eyesi Direct: Die Bewertung des Simulators ergab am ersten Praktikumstag für beide Gruppen keinen signifikant unterschiedlichen Wissensstand (p = 0,29). In der Gruppe OHNE Training (n = 54) ergab sich am letzten Praktikumstag mit p = 0,02 eine signifikante Verbesserung dieser Bewertung, jedoch mit einer geringen Effektgröße von 0,1. In der Gruppe MIT Training (n = 32) konnte mit p = 0,0004 eine hoch signifikante Verbesserung mit einer Effektgröße von 0,3 nach Rosenthal festgestellt werden. Eyesi Indirect: Die simulatorgestützte Bewertung ergab am ersten Praktikumstag keinen signifikanten Unterschied im Wissensstand der beiden Gruppen (p = 0,1). Nach dem Training schnitten zwar beide Gruppen etwas besser ab, jedoch ohne signifikanten Unterschied (OHNE Training p = 0,41/MIT Training p = 0,17).
Diskussion: Die Online-Plattform EyesiNet unterstützt beim Erlernen der wichtigsten Erkrankungsbilder. Lerninhalte werden reproduzierbar und auf für alle Lernenden standardisierte Weise zur Verfügung gestellt. Die Fertigkeiten der direkten Ophthalmoskopie sind hierbei deutlich schneller als die der indirekten Ophthalmoskopie zu erlernen.
Background: Bipolar disorder is associated with circadian disruption and a high risk of suicidal behavior. In a previous exploratory study of patients with bipolar I disorder, we found that a history of suicide attempts was associated with differences between winter and summer levels of solar insolation. The purpose of this study was to confirm this finding using international data from 42% more collection sites and 25% more countries. Methods: Data analyzed were from 71 prior and new collection sites in 40 countries at a wide range of latitudes. The analysis included 4876 patients with bipolar I disorder, 45% more data than previously analyzed. Of the patients, 1496 (30.7%) had a history of suicide attempt. Solar insolation data, the amount of the sun’s electromagnetic energy striking the surface of the earth, was obtained for each onset location (479 locations in 64 countries). Results: This analysis confirmed the results of the exploratory study with the same best model and slightly better statistical significance. There was a significant inverse association between a history of suicide attempts and the ratio of mean winter insolation to mean summer insolation (mean winter insolation/mean summer insolation). This ratio is largest near the equator which has little change in solar insolation over the year, and smallest near the poles where the winter insolation is very small compared to the summer insolation. Other variables in the model associated with an increased risk of suicide attempts were a history of alcohol or substance abuse, female gender, and younger birth cohort. The winter/summer insolation ratio was also replaced with the ratio of minimum mean monthly insolation to the maximum mean monthly insolation to accommodate insolation patterns in the tropics, and nearly identical results were found. All estimated coefficients were significant at p < 0.01. Conclusion: A large change in solar insolation, both between winter and summer and between the minimum and maximum monthly values, may increase the risk of suicide attempts in bipolar I disorder. With frequent circadian rhythm dysfunction and suicidal behavior in bipolar disorder, greater understanding of the optimal roles of daylight and electric lighting in circadian entrainment is needed.
Purpose: Acute elbow dislocations are complex injuries that predispose to chronic instability and pain. The ideal treatment strategy is part of controversial discussion and evidence-based recommendations for the treatment could not be concluded from the literature. The purpose of the present study was to assess current epidemiological data, injury pattern, and the changing trend for treatment.
Methods: This study presents a retrospective review of 72 patients ≥ 18 years of age who were treated in our level I trauma centre with acute elbow dislocations from 2014 to 2018. The data were acquired by analysis of the institution’s database, and radiological examinations.
Results: The average age of the patients was 48.5 years (range 18–86). The ratio of male to female patients was 1.9:1. A fall onto the outstretched arm (42%) was the most common injury mechanism. By classification, 42% of the elbow dislocations were simple, and 58% complex. A total of 85% of patients underwent surgery including 73% of the simple elbow dislocations due to remaining instability or non-congruency of the reduced elbow. The indication for surgical treatment correlated merely with the grade of instability and displacement, but not with age.
Conclusion: Acute elbow dislocations need identification of the precise injury pattern and instability after reduction of the elbow joint. To achieve a congruent and stable joint, we recommend primary surgical repair as first-line treatment for patients with unstable simple and complex elbow dislocation independent of age.
Background: Rare diseases are, by definition, very serious and chronic diseases with a high negative impact on quality of life. Approximately 350 million people worldwide live with rare diseases. The resulting high disease burden triggers health information search, but helpful, high-quality, and up-to-date information is often hard to find. Therefore, the improvement of health information provision has been integrated in many national plans for rare diseases, discussing the telephone as one access option. In this context, this study examines the need for a telephone service offering information for people affected by rare diseases, their relatives, and physicians.
Methods: In total, 107 individuals participated in a qualitative interview study conducted in Germany. Sixty-eight individuals suffering from a rare disease or related to somebody with rare diseases and 39 health care professionals took part. Individual interviews were conducted using a standardized semi-structured questionnaire. Interviews were analysed using the qualitative content analysis, triangulating patients, relatives, and health care professionals. The fulfilment of qualitative data processing standards has been controlled for.
Results: Out of 68 patients and relatives and 39 physicians, 52 and 18, respectively, advocated for the establishment of a rare diseases telephone service. Interviewees expected a helpline to include expert staffing, personal contact, good availability, low technical barriers, medical and psychosocial topics of counselling, guidance in reducing information chaos, and referrals. Health care professionals highlighted the importance of medical topics of counselling—in particular, differential diagnostics—and referrals.
Conclusions: Therefore, the need for a national rare diseases helpline was confirmed in this study. Due to limited financial resources, existing offers should be adapted in a stepwise procedure in accordance with the identified attributes.
Background: Recently, public and political interest has focused on people living with rare diseases and their health concerns. Due to the large number of different types of rare diseases and the sizable number of patients, taking action to improve the life of those affected is gaining importance. In 2013, the federal government of Germany adopted a national action plan for rare diseases, including the call to establish a central information portal on rare diseases (Zentrales Informationsportal über seltene Erkrankungen, ZIPSE).
Objective: The objective of this study, therefore, was to conduct scientific research on how such a portal must be designed to meet the needs of patients, their families, and medical professionals, and to provide high-quality information for information seekers.
Methods: We chose a 3-step procedure to develop a needs-based prototype of a central information portal. In the first step, we determined the information needs of patients with rare diseases, their relatives, and health care professionals by means of qualitative interviews and their content-analytical evaluation. On the basis of this, we developed the basic structure of the portal. In the second step, we identified quality criteria for websites on rare diseases to ensure that the information linked with ZIPSE meets the quality demands. Therefore, we gathered existing criteria catalogs and discussed them in an expert workshop. In the third step, we implemented and tested the developed prototypical information portal.
Results: A portal page was configured and made accessible on the Web. The structure of ZIPSE was based on the findings from 108 qualitative interviews with patients, their relatives, and health care professionals, through which numerous information needs were identified. We placed particularly important areas of information, such as symptoms, therapy, research, and advisory services, on the start page. Moreover, we defined 13 quality criteria, referring to factors such as author information, creation date, and privacy, enabling links with high-quality information. Moreover, 19 users tested all the developed routines based on usability and comprehensibility. Subsequently, we improved the visual presentation of search results and other important search functions.
Conclusions: The implemented information portal, ZIPSE, provides high-quality information on rare diseases from a central point of access. By integrating the targeted groups as well as different experts on medical information during the construction, the website can assure an improved search for information for users. ZIPSE can also serve as a model for other Web-based information systems in the field of rare diseases.
Registered Report Identifier: RR1-10.2196/7425.
Crista junctions (CJs) are important for mitochondrial organization and function, but the molecular basis of their formation and architecture is obscure. We have identified and characterized a mitochondrial membrane protein in yeast, Fcj1 (formation of CJ protein 1), which is specifically enriched in CJs. Cells lacking Fcj1 lack CJs, exhibit concentric stacks of inner membrane in the mitochondrial matrix, and show increased levels of F1FO–ATP synthase (F1FO) supercomplexes. Overexpression of Fcj1 leads to increased CJ formation, branching of cristae, enlargement of CJ diameter, and reduced levels of F1FO supercomplexes. Impairment of F1FO oligomer formation by deletion of its subunits e/g (Su e/g) causes CJ diameter enlargement and reduction of cristae tip numbers and promotes cristae branching. Fcj1 and Su e/g genetically interact. We propose a model in which the antagonism between Fcj1 and Su e/g locally modulates the F1FO oligomeric state, thereby controlling membrane curvature of cristae to generate CJs and cristae tips.
Cloud microphysical processes involving the ice phase in tropospheric clouds are among the major uncertainties in cloud formation, weather and General Circulation Models (GCMs). The simultaneous detection of aerosol particles, liquid droplets, and ice crystals, especially in the small cloud-particle size range below 50 µm, remains challenging in mixed phase, often unstable ice-water phase environments. The Cloud Aerosol Spectrometer with Polarisation (CASPOL) is an airborne instrument that has the ability to detect such small cloud particles and measure their effects on the backscatter polarisation state. Here we operate the versatile Cosmics-Leaving- OUtdoor-Droplets (CLOUD) chamber facility at the European Organisation for Nuclear Research (CERN) to produce controlled mixed phase and other clouds by adiabatic expansions in an ultraclean environment, and use the CASPOL to discriminate between different aerosols, water and ice particles. In this paper, optical property measurements of mixed phase clouds and viscous Secondary Organic Aerosol (SOA) are presented. We report observations of significant liquid – viscous SOA particle polarisation transitions under dry conditions using CASPOL. Cluster analysis techniques were subsequently used to classify different types of particles according to their polarisation ratios during phase transition. A classification map is presented for water droplets, organic aerosol (e.g., SOA and oxalic acid), crystalline substances such as ammonium sulphate, and volcanic ash. Finally, we discuss the benefits and limitations of this classi- fication approach for atmospherically relevant concentration and mixtures with respect to the CLOUD 8–9 campaigns and its potential contribution to Tropical Troposphere Layer (TTL) analysis.
The growth of aerosol due to the aqueous phase oxidation of sulfur dioxide by ozone was measured in laboratory-generated clouds created in the Cosmics Leaving OUtdoor Droplets (CLOUD) chamber at the European Organization for Nuclear Research (CERN). Experiments were performed at 10 and −10 °C, on acidic (sulfuric acid) and on partially to fully neutralised (ammonium sulfate) seed aerosol. Clouds were generated by performing an adiabatic expansion – pressurising the chamber to 220 hPa above atmospheric pressure, and then rapidly releasing the excess pressure, resulting in a cooling, condensation of water on the aerosol and a cloud lifetime of approximately 6 min. A model was developed to compare the observed aerosol growth with that predicted using oxidation rate constants previously measured in bulk solutions. The model captured the measured aerosol growth very well for experiments performed at 10 and −10 °C, indicating that, in contrast to some previous studies, the oxidation rates of SO2 in a dispersed aqueous system can be well represented by using accepted rate constants, based on bulk measurements. To the best of our knowledge, these are the first laboratory-based measurements of aqueous phase oxidation in a dispersed, super-cooled population of droplets. The measurements are therefore important in confirming that the extrapolation of currently accepted reaction rate constants to temperatures below 0 °C is correct.
The growth of aerosol due to the aqueous phase oxidation of sulfur dioxide by ozone was measured in laboratory-generated clouds created in the Cosmics Leaving OUtdoor Droplets (CLOUD) chamber at the European Organization for Nuclear Research (CERN). Experiments were performed at 10 and −10 °C, on acidic (sulfuric acid) and on partially to fully neutralised (ammonium sulfate) seed aerosol. Clouds were generated by performing an adiabatic expansion – pressurising the chamber to 220 hPa above atmospheric pressure, and then rapidly releasing the excess pressure, resulting in a cooling, condensation of water on the aerosol and a cloud lifetime of approximately 6 min. A model was developed to compare the observed aerosol growth with that predicted using oxidation rate constants previously measured in bulk solutions. The model captured the measured aerosol growth very well for experiments performed at 10 and −10 °C, indicating that, in contrast to some previous studies, the oxidation rates of SO2 in a dispersed aqueous system can be well represented by using accepted rate constants, based on bulk measurements. To the best of our knowledge, these are the first laboratory-based measurements of aqueous phase oxidation in a dispersed, super-cooled population of droplets. The measurements are therefore important in confirming that the extrapolation of currently accepted reaction rate constants to temperatures below 0 °C is correct.
Cloud microphysical processes involving the ice phase in tropospheric clouds are among the major uncertainties in cloud formation, weather, and general circulation models. The detection of aerosol particles, liquid droplets, and ice crystals, especially in the small cloud particle-size range below 50 μm, remains challenging in mixed phase, often unstable environments. The Cloud Aerosol Spectrometer with Polarization (CASPOL) is an airborne instrument that has the ability to detect such small cloud particles and measure the variability in polarization state of their backscattered light. Here we operate the versatile Cosmics Leaving OUtdoor Droplets (CLOUD) chamber facility at the European Organization for Nuclear Research (CERN) to produce controlled mixed phase and other clouds by adiabatic expansions in an ultraclean environment, and use the CASPOL to discriminate between different aerosols, water, and ice particles. In this paper, optical property measurements of mixed-phase clouds and viscous secondary organic aerosol (SOA) are presented. We report observations of significant liquid–viscous SOA particle polarization transitions under dry conditions using CASPOL. Cluster analysis techniques were subsequently used to classify different types of particles according to their polarization ratios during phase transition. A classification map is presented for water droplets, organic aerosol (e.g., SOA and oxalic acid), crystalline substances such as ammonium sulfate, and volcanic ash. Finally, we discuss the benefits and limitations of this classification approach for atmospherically relevant concentrations and mixtures with respect to the CLOUD 8–9 campaigns and its potential contribution to tropical troposphere layer analysis.
Background: Chronic congestive heart failure (CHF) is a complex disease with rising prevalence, compromised quality of life (QoL), unplanned hospital admissions, high mortality and therefore high burden of illness. The delivery of care for these patients has been criticized and new strategies addressing crucial domains of care have been shown to be effective on patients' health outcomes, although these trials were conducted in secondary care or in highly organised Health Maintenance Organisations. It remains unclear whether a comprehensive primary care-based case management for the treating general practitioner (GP) can improve patients' QoL. Methods/Design: HICMan is a randomised controlled trial with patients as the unit of randomisation. Aim is to evaluate a structured, standardized and comprehensive complex intervention for patients with CHF in a 12-months follow-up trial. Patients from intervention group receive specific patient leaflets and documentation booklets as well as regular monitoring and screening by a prior trained practice nurse, who gives feedback to the GP upon urgency. Monitoring and screening address aspects of disease-specific selfmanagement, (non)pharmacological adherence and psychosomatic and geriatric comorbidity. GPs are invited to provide a tailored structured counselling 4 times during the trial and receive an additional feedback on pharmacotherapy relevant to prognosis (data of baseline documentation). Patients from control group receive usual care by their GPs, who were introduced to guidelineoriented management and a tailored health counselling concept. Main outcome measurement for patients' QoL is the scale physical functioning of the SF-36 health questionnaire in a 12-month follow-up. Secondary outcomes are the disease specific QoL measured by the Kansas City Cardiomyopathy questionnaire (KCCQ), depression and anxiety disorders (PHQ-9, GAD-7), adherence (EHFScBS and SANA), quality of care measured by an adapted version of the Patient Chronic Illness Assessment of Care questionnaire (PACIC) and NTproBNP. In addition, comprehensive clinical data are collected about health status, comorbidity, medication and health care utilisation. Discussion: As the targeted patient group is mostly cared for and treated by GPs, a comprehensive primary care-based guideline implementation including somatic, psychosomatic and organisational aspects of the delivery of care (HICMAn) is a promising intervention applying proven strategies for optimal care. Trial registration: Current Controlled Trials ISRCTN30822978.